(IMAGE)

Hiroshima University

Caption

CML stem cells, the cellular source of a vast majority of differentiated CML cells, are reportedly responsible for the recurrence of CML, following TKI therapy.

Credit

Hiroshima University

Usage Restrictions

This image may only be used with appropriate caption and credit.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.